These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 750110)
21. Biodistribution of misonidazole and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in rats bearing unclamped and clamped 9L subcutaneous tumors. Wong KH; Wallen CA; Wheeler KT Int J Radiat Oncol Biol Phys; 1989 Jul; 17(1):135-43. PubMed ID: 2745188 [TBL] [Abstract][Full Text] [Related]
22. Effect of administration schedules on the potentiation of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) by misonidazole in subcutaneous 9L tumors. Wong KH; Zhang H; Wallen CA; Wheeler KT Int J Radiat Oncol Biol Phys; 1992; 23(4):831-9. PubMed ID: 1618675 [TBL] [Abstract][Full Text] [Related]
23. Effect of thymidine on uptake, DNA alkylation, and DNA repair in L1210 cells treated with 1,3-bis(2-chloroethyl)-1-nitrosourea or 3'-[3-(2-chloroethyl)-3-nitrosoureido]-3'-deoxythymidine. August EM; Prusoff WH Cancer Res; 1988 Aug; 48(15):4272-5. PubMed ID: 3390823 [TBL] [Abstract][Full Text] [Related]
24. Glutathione and related enzymes in rat brain tumor cell resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea and nitrogen mustard. Evans CG; Bodell WJ; Tokuda K; Doane-Setzer P; Smith MT Cancer Res; 1987 May; 47(10):2525-30. PubMed ID: 2882834 [TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of nitrosoureas: levels of 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) in organs of normal and Walker 256/B carcinoma bearing rats after i.v. bolus. Bartosek I; Russo RG; Cattaneo MT Tumori; 1984 Dec; 70(6):491-8. PubMed ID: 6531791 [TBL] [Abstract][Full Text] [Related]
26. Invasive phenotype observed in 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant sublines of 9L rat glioma cells: a tumor model mimicking a recurrent malignant glioma. Saito R; Bringas J; Mirek H; Berger MS; Bankiewicz KS J Neurosurg; 2004 Nov; 101(5):826-31. PubMed ID: 15540922 [TBL] [Abstract][Full Text] [Related]
27. Denitrosation of 1,3-bis(2-chloroethyl)-1-nitrosourea by class mu glutathione transferases and its role in cellular resistance in rat brain tumor cells. Smith MT; Evans CG; Doane-Setzer P; Castro VM; Tahir MK; Mannervik B Cancer Res; 1989 May; 49(10):2621-5. PubMed ID: 2713846 [TBL] [Abstract][Full Text] [Related]
28. Laboratory studies of berberine used alone and in combination with 1,3-bis(2-chloroethyl)-1-nitrosourea to treat malignant brain tumors. Zhang RX; Dougherty DV; Rosenblum ML Chin Med J (Engl); 1990 Aug; 103(8):658-65. PubMed ID: 2122945 [TBL] [Abstract][Full Text] [Related]
29. Increased mutagenicity of chloroethylnitrosoureas in the presence of a rat liver S9 microsome mixture. Suling WJ; Rice LS; Shannon WM J Natl Cancer Inst; 1983 Apr; 70(4):767-9. PubMed ID: 6220173 [TBL] [Abstract][Full Text] [Related]
30. Active site specific inactivation of chymotrypsin by cyclohexyl isocyanate formed during degradation of the carcinostatic 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea. Babson JR; Reed DJ; Sinkey MA Biochemistry; 1977 Apr; 16(8):1584-9. PubMed ID: 856251 [TBL] [Abstract][Full Text] [Related]
31. Microsomal metabolism of nitrosoureas. Hill DL; Kirk MC; Struck RF Cancer Res; 1975 Feb; 35(2):296-301. PubMed ID: 234031 [TBL] [Abstract][Full Text] [Related]
32. Phase II study of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) in the treatment of brain tumors. Fewer D; Wilson CB; Boldrey EB; Enot JK Cancer Chemother Rep; 1972 Jun; 56(3):421-7. PubMed ID: 19051504 [TBL] [Abstract][Full Text] [Related]
33. 2-Nitroimidazole potentiation of nitrosourea induced cytotoxicity in subcutaneous implants of rat 9L brain tumor cells. Wong KH; Wallen CA; Wheeler KT J Neurooncol; 1991 Aug; 11(1):17-25. PubMed ID: 1833513 [TBL] [Abstract][Full Text] [Related]
34. Potentiation of the antitumor therapeutic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea by alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor. Marton LJ; Levin VA; Hervatin SJ; Koch-Weser J; McCann PP; Sjoerdsma A Cancer Res; 1981 Nov; 41(11 Pt 1):4426-31. PubMed ID: 6796258 [TBL] [Abstract][Full Text] [Related]
35. Mechanism of action of (2-haloethyl)nitrosoureas on DNA. Isolation and reactions of postulated 2-(alkylimino)-3-nitrosooxazolidine intermediates in the decomposition of 1,3-bis(2-chloroethyl)-, 1-(2-chloroethyl)-3-cyclohexyl-, and 1-(2-chloroethyl)-3-(4'-trans-methylcyclohexyl)-1-nitrosourea. Lown JW; Chauhan SM J Med Chem; 1981 Mar; 24(3):270-9. PubMed ID: 7265113 [TBL] [Abstract][Full Text] [Related]
36. Comparison of the CCNU and BCNU modification of the in vitro radiation response in 9L brain tumor cells of rats. Deen DF; Williams ME; Wheeler KT Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1541-4. PubMed ID: 536259 [No Abstract] [Full Text] [Related]
37. Clinical toxicity of combined modality treatment with nitrosourea derivatives for central nervous system tumors. Robustelli della Cuna G; Paoletti P; Bernardo G; Knerich R; Butti G; Cuzzoni Q Neurosurgery; 1982 Sep; 11(3):408-11. PubMed ID: 6290930 [TBL] [Abstract][Full Text] [Related]
38. Interference with effects of amphotericin B on Candida albicans cells by 2-chloroethyl-1-nitrosoureas. Brajtburg J; Elberg S; Kobayashi GS; Medoff G Antimicrob Agents Chemother; 1988 Mar; 32(3):327-30. PubMed ID: 3284460 [TBL] [Abstract][Full Text] [Related]
39. Measurement of sister chromatid exchange induction in intracerebral brain tumors as a method for evaluation of therapeutic drug combinations. Bodell WJ Anticancer Res; 2000; 20(5A):3099-103. PubMed ID: 11062728 [TBL] [Abstract][Full Text] [Related]
40. Antitumor activity of 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-(4-methyl-cyclohexyl)-1-nitrosourea (MeCCNU) on Yoshida sarcoma ascites cells implanted into the colon wall of rats. Bhide S; Habs M; Reinbold H; Schmähl D J Cancer Res Clin Oncol; 1979 May; 94(1):63-7. PubMed ID: 468900 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]